RGNX logo

REGENXBIO (RGNX) Current Liabilities

Annual Current Liabilities

$130.27 M
-$162.00 K-0.12%

31 December 2023

RGNX Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$102.72 M
+$4.45 M+4.53%

30 September 2024

RGNX Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGNX Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.1%-19.3%
3 y3 years+60.0%-3.8%
5 y5 years+487.4%+227.7%

RGNX Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-0.1%+60.0%-21.3%+4.5%
5 y5 years-0.1%+487.4%-21.3%+227.7%
alltimeall time-0.1%+2902.3%-21.3%+2267.5%

REGENXBIO Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$102.72 M(+4.5%)
June 2024
-
$98.27 M(-10.8%)
Mar 2024
-
$110.18 M(-15.4%)
Dec 2023
$130.27 M(-0.1%)
$130.27 M(+2.3%)
Sept 2023
-
$127.35 M(+8.0%)
June 2023
-
$117.89 M(+4.9%)
Mar 2023
-
$112.33 M(-13.9%)
Dec 2022
$130.43 M(-0.0%)
$130.43 M(+5.6%)
Sept 2022
-
$123.55 M(+7.8%)
June 2022
-
$114.56 M(-4.5%)
Mar 2022
-
$119.94 M(-8.1%)
Dec 2021
$130.47 M(+60.2%)
$130.47 M(+22.2%)
Sept 2021
-
$106.77 M(+16.6%)
June 2021
-
$91.55 M(+9.0%)
Mar 2021
-
$83.96 M(+3.1%)
Dec 2020
$81.45 M(+141.9%)
$81.45 M(+28.0%)
Sept 2020
-
$63.61 M(+58.2%)
June 2020
-
$40.20 M(+26.5%)
Mar 2020
-
$31.79 M(-5.6%)
Dec 2019
$33.68 M
$33.68 M(+7.4%)
DateAnnualQuarterly
Sept 2019
-
$31.34 M(+27.1%)
June 2019
-
$24.66 M(+15.3%)
Mar 2019
-
$21.39 M(-3.5%)
Dec 2018
$22.18 M(+53.6%)
$22.18 M(+16.0%)
Sept 2018
-
$19.12 M(+13.5%)
June 2018
-
$16.85 M(+13.3%)
Mar 2018
-
$14.88 M(+3.0%)
Dec 2017
$14.44 M(+49.3%)
$14.44 M(+7.7%)
Sept 2017
-
$13.40 M(+16.9%)
June 2017
-
$11.46 M(+15.1%)
Mar 2017
-
$9.96 M(+3.0%)
Dec 2016
$9.67 M(+122.8%)
$9.67 M(-32.8%)
Sept 2016
-
$14.38 M(+57.2%)
June 2016
-
$9.15 M(+58.3%)
Mar 2016
-
$5.78 M(+33.2%)
Dec 2015
$4.34 M(-52.8%)
$4.34 M(-18.3%)
Sept 2015
-
$5.31 M(-12.1%)
June 2015
-
$6.04 M(-34.3%)
Dec 2014
$9.19 M(+97.5%)
$9.19 M
Dec 2013
$4.65 M
-

FAQ

  • What is REGENXBIO annual total current liabilities?
  • What is the all time high annual current liabilities for REGENXBIO?
  • What is REGENXBIO annual current liabilities year-on-year change?
  • What is REGENXBIO quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for REGENXBIO?
  • What is REGENXBIO quarterly current liabilities year-on-year change?

What is REGENXBIO annual total current liabilities?

The current annual current liabilities of RGNX is $130.27 M

What is the all time high annual current liabilities for REGENXBIO?

REGENXBIO all-time high annual total current liabilities is $130.47 M

What is REGENXBIO annual current liabilities year-on-year change?

Over the past year, RGNX annual total current liabilities has changed by -$162.00 K (-0.12%)

What is REGENXBIO quarterly total current liabilities?

The current quarterly current liabilities of RGNX is $102.72 M

What is the all time high quarterly current liabilities for REGENXBIO?

REGENXBIO all-time high quarterly total current liabilities is $130.47 M

What is REGENXBIO quarterly current liabilities year-on-year change?

Over the past year, RGNX quarterly total current liabilities has changed by -$24.62 M (-19.33%)